Skip to main content
. 2021 May 1;25(3):197–206. doi: 10.4196/kjpp.2021.25.3.197

Table 1.

Upregulated osteogenic genes by carnosol during osteogenic differentiation of mBMSCs

Gene name Gene symbol Fold change
Ossification and matrix molecules
Alkaline phosphatase, liver/bone/kidney Alpl 10.5
Bone gamma carboxyglutamate protein Bglap 8.3
Biglycan Bgn 3.8
Collagen type I alpha 1 Col1a1 5.7
Collagen type V alpha 1 Col5a1 4.8
Secreted phosphoprotein 1 (Osteopontin) Spp1 3.2
Osteoblast differentiation
Bone morphogenetic protein 2 Bmp2 5.2
Bone morphohenitic protein 4 Bmp4 6.4
Bone morphogenetic protein receptor, type 1A Bmpr1a 2.1
Bone morphohenitic protein receptor, type 1B Bmpr1a 6.3
Distal-less homeobox 5 Dlx5 7.3
Runt related transcription factor 2 Runx2 4.6
Sp7 transcription factor 7 Sp7 2.3
Cell adhesion molecules
Fibronectin 1 Fn1 3.4
Integrin beta 1 (fibronectin receptor beta) Itgb1 2.3
Integrin alpha 2 Itga2 2.8
Integrin alpha 2b Itga2b 3.4
Osteogenic growth factors
Fibroblast growth factor receptor 2 Fgfr2 3.9
Insulin-like growth factor 1 Igf1 8.4
Insulin-like growth factor I receptor Igf1r 4.3
Platelet derived growth factor alpha Pdgfa 5.2
Vascular endothelial growth factor A Vegfa 3.1

Cells were induced to differentiate into osteoblast in the absence (control) or the presence of carnosol (10 µM). After 6 days of induction, total RNA were extracted and Mouse osteogenesis RT2 Profiler PCR array was performed was performed using quantitative PCR method. Up-regulated genes by carnosol were normalized to reference genes and represented as fold change over control cells without carnosol. Values are mean of 3 independent experiments. mBMSCs, mouse bone marrow-derived mesenchymal stem cells.